Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8901120
SERIAL NO

13436910

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In one aspect, the invention relates to substituted N-phenylpyrimidin-2-amine analogs, derivatives thereof, and related compounds, which are useful as inhibitors of Axl kinase; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions for treating disorders associated with dysfunction of the Axl kinase. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • UNIVERSITY OF UTAH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bearss, David J Alpine, US 86 1447
Mollard, Alexis Salt Lake City, US 7 72
Sharma, Sunil Salt Lake City, US 51 462
Vankayalapati, Hariprasad Draper, US 74 1085
Warner, Steven L Sandy, US 65 665

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 2, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00